```html

Xanthoma Striatum Palmare: A Complete Patient Guide

What is Xanthoma Striatum Palmare?

Xanthoma striatum palmare (sometimes called “palmar xanthoma”) is a distinctive, orange‑yellow, band‑like or streaked buildup of lipid‑laden (fatty) cells called foam cells that appears on the palmar (palm) surface of the hands. These lesions are most often noticed on the thenar and hypothenar areas (the fleshy parts at the base of the fingers) and can extend in a linear pattern along the palmar creases.

Although they are not painful, their unusual color and pattern can cause cosmetic concern and, more importantly, they frequently serve as a visual clue that an underlying lipid disorder or systemic disease is present. Recognizing xanthoma striatum palmare early can prompt timely evaluation of potentially serious metabolic conditions.

Common Causes

The presence of palmar xanthomas is most often linked to disorders that cause elevated levels of certain lipids in the blood. The most common underlying conditions include:

• Familial hypercholesterolemia (FH) – an autosomal‑dominant genetic disorder causing very high LDL‑cholesterol.
• Familial hypertriglyceridemia – elevated triglycerides due to genetic or secondary factors.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia) – a rare defect in apoE that leads to accumulation of chylomicron and VLDL remnants.
• Primary (genetic) lipoprotein lipase deficiency – impaired breakdown of triglyceride‑rich particles.
• Secondary hyperlipidemia related to uncontrolled diabetes mellitus – especially type 2 diabetes with poor glycemic control.
• Hypothyroidism – reduced thyroid hormone leads to decreased LDL‑receptor activity.
• Chronic kidney disease (nephrotic syndrome) – loss of proteins in urine stimulates hepatic lipoprotein synthesis.
• Alcoholic liver disease – excess alcohol can raise VLDL and triglycerides.
• Medications such as retinoids, protease inhibitors, or high‑dose corticosteroids that elevate lipid levels.
• Rare storage diseases (e.g., Niemann‑Pick disease) – lysosomal storage disorders that cause lipid accumulation.

In many patients, the xanthoma appears before the lipid abnormality is diagnosed, making it a valuable early warning sign.

Associated Symptoms

While the lesions themselves are usually asymptomatic, the underlying conditions may produce other signs:

• Other skin xanthomas – tendon (Achilles) xanthomas, eruptive or tuberous xanthomas on elbows, knees, or buttocks.
• Premature or extensive atherosclerotic disease – chest pain, claudication, or transient ischemic attacks.
• Fatigue, weakness, or unexplained weight loss – common in uncontrolled diabetes or thyroid disease.
• Glucose intolerance symptoms – polyuria, polydipsia, blurred vision.
• Signs of hypothyroidism – cold intolerance, dry skin, constipation, hair loss.
• Swelling around the eyes (periorbital edema) or generalized edema in nephrotic syndrome.
• Abdominal discomfort in severe hypertriglyceridemia, which can progress to pancreatitis.

When to See a Doctor

Because palmar xanthomas can indicate a serious metabolic disorder, you should schedule an appointment if:

• You notice new yellow‑orange streaks or patches on your palms, especially if they persist for weeks.
• You have a personal or family history of high cholesterol, early heart disease, or stroke.
• You experience any of the associated symptoms listed above (e.g., chest pain, sudden weakness, worsening diabetes control).
• Existing lipid‑lowering therapy no longer controls your cholesterol or triglyceride levels.
• You are pregnant or planning pregnancy and have a known lipid disorder (some therapies are contraindicated).

Early evaluation allows for targeted treatment that can reduce cardiovascular risk and prevent skin changes from worsening.

Diagnosis

Diagnosis is a stepwise process that combines visual assessment, laboratory testing, and sometimes imaging.

1. Clinical examination

• Dermatologic inspection of the palms and other body sites.
• Documentation of size, distribution, and color of lesions (photos are helpful for follow‑up).

2. Laboratory evaluation

• Lipid profile – total cholesterol, LDL‑C, HDL‑C, triglycerides, and VLDL.
• Apolipoprotein E (apoE) genotyping – especially if type III hyperlipoproteinemia is suspected.
• Basic metabolic panel, fasting glucose, HbA1c – to assess diabetes.
• Thyroid‑stimulating hormone (TSH) and free T4 – to rule out hypothyroidism.
• Renal function tests (creatinine, urine protein) – for nephrotic syndrome.
• Liver function tests – to detect alcoholic or non‑alcoholic fatty liver disease.

3. Imaging (when indicated)

• Ultrasound or CT angiography – to evaluate for atherosclerotic plaque if cardiovascular risk is high.
• Skin biopsy – rarely needed, but histology shows lipid‑laden macrophages confirming a xanthoma.

4. Genetic testing

For patients with a strong family history or very early onset disease, DNA testing for FH (LDLR, APOB, PCSK9) or other lipid‑disorder genes can be performed.

Treatment Options

Treatment targets two goals: (1) reducing or eliminating the skin lesions and (2) correcting the underlying metabolic abnormality to lower cardiovascular risk.

1. Lifestyle modifications

• Dietary changes – adopt a heart‑healthy diet low in saturated fat, trans‑fat, and refined carbohydrates; increase omega‑3 fatty acids, soluble fiber, and plant sterols.
• Weight management – achieving a BMI < 25 kg/m² can substantially improve triglycerides and LDL‑C.
• Physical activity – at least 150 minutes of moderate aerobic exercise per week.
• Alcohol moderation – limit intake to ≤ 1 drink/day for women and ≤ 2 drinks/day for men; abstain if triglycerides are > 500 mg/dL.
• Smoking cessation – eliminates an additional cardiovascular risk factor.

2. Pharmacologic therapy

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line for lowering LDL‑C; also modestly reduce triglycerides.
• Ezetimibe – added when LDL‑C goals are not met with statins alone.
• PCSK9 inhibitors (alirocumab, evolocumab) – potent LDL‑C reducers, especially useful in familial hypercholesterolemia.
• Fibrates (fenofibrate, gemfibrozil) – primary agents for severe hypertriglyceridemia.
• Omega‑3 ethyl esters (e.g., icosapent ethyl) – lower triglycerides and may help regress xanthomas.
• Niacin – can improve HDL‑C and lower triglycerides, but used less frequently due to side‑effects.
• Thyroid hormone replacement – levothyroxine for hypothyroidism; normalizing TSH often improves lipid profile.
• Management of diabetes – metformin, GLP‑1 receptor agonists, or SGLT2 inhibitors to improve glycemic control and lipid parameters.

3. Dermatologic interventions (optional)

• Laser therapy – CO₂ or pulsed dye lasers can reduce visible lesions after lipid levels are controlled.
• Cryotherapy or surgical excision – rarely needed; considered only for persistent, cosmetically distressing lesions.
• Note: skin‑directed treatments do NOT replace the need for systemic lipid control.

4. Follow‑up

Patients should have lipid panels checked every 3–6 months until targets are reached, then annually. Repeat skin examinations help gauge regression of the xanthomas.

Prevention Tips

While you cannot always prevent a genetic lipid disorder, you can limit its impact and reduce the chance of developing xanthoma striatum palmare:

• Screen family members early if a genetic disorder is diagnosed (cascade screening).
• Maintain a diet rich in fruits, vegetables, whole grains, nuts, and fatty fish.
• Exercise regularly and keep a healthy weight.
• Control blood sugar levels if you have diabetes; aim for HbA1c < 7 % (or individualized target).
• Take prescribed lipid‑lowering medications exactly as directed.
• Have your thyroid function checked at least every 5 years, more often if you have symptoms.
• Avoid excessive alcohol and stop smoking.
• Schedule routine health‑check visits—early detection of abnormal lipids saves lives.

Emergency Warning Signs

Key Take‑aways

Xanthoma striatum palmare is more than a cosmetic curiosity; it is a visual marker of lipid disturbances that can herald serious cardiovascular or systemic disease. Recognizing the pattern, obtaining a thorough lipid work‑up, and initiating both lifestyle and pharmacologic therapy can dramatically lower long‑term risk and often lead to regression of the skin lesions. If you notice the characteristic orange‑yellow streaks on your palms, schedule a medical evaluation promptly.

References: Mayo Clinic. “Xanthomas”; CDC. “High Blood Cholesterol”; NIH. “Familial Hypercholesterolemia”; WHO. “Noncommunicable diseases”; Cleveland Clinic. “Lipid Disorders”; J Am Coll Cardiol. 2023;81(15):1445‑1460.

```